Login / Signup

Longitudinal Feasibility of the Montreal Cognitive Assessment (MoCA) in Non-Demented ALS Patients.

Edoardo Nicolò AielloFederica SolcaSilvia TorreEleonora ColomboAlessio MaranzanoAlberto De LorenzoValerio PatissoMauro TreddentiBeatrice CurtiClaudia MorelliAlberto DorettiFederico VerdeRoberta FerrucciSergio BarbieriFabiana RuggieroAlberto PrioriVincenzo SilaniNicola TicozziBarbara Poletti
Published in: European neurology (2024)
As long as motor disabilities do not undermine its applicability, the MoCA appears to be longitudinally feasible at a 5-to-10-month interval in non-demented ALS patients. However, ALS-specific screeners - such as the ECAS - should be preferred whenever possible.
Keyphrases
  • end stage renal disease
  • ejection fraction
  • newly diagnosed
  • chronic kidney disease
  • prognostic factors
  • amyotrophic lateral sclerosis
  • cross sectional